Table 1.
Total cholesterol analysis of male patients treated with and without Finasteride: NHANES 2009–2016a
| Total Cholesterol levels in subjects taking finasteride: NHANES 2009-2016 | ||||||
|---|---|---|---|---|---|---|
| Interaction variable | No finasteride |
Finasteride |
P | Test for interaction |
||
| Mean ± SE | Mean ± SE | F | P | |||
| Alcohol > four or five drinks per day | Yes | 174 ± 3 | 138 ± 8 | 0.0002 | 2.78 | 0.1006 |
| No | 174 ± 3 | 152 ± 5 | 0.0001 | |||
| Diagnosed with cardiovascular disease | Yes | 170 ± 4 | 124 ± 9 | <0.0001 | 10.6 | 0.0018 |
| No | 178 ± 3 | 166 ± 5 | 0.0253 | |||
| Taking drugs that affect glucose metabolism | Yes | 171 ± 3 | 155 ± 5 | 0.0105 | 6.12 | 0.0161 |
| No | 178 ± 4 | 135 ± 9 | <0.0001 | |||
a
Statistical differences were considered significant when P < 0.05 and P < 0.15 for differences in means between No finasteride and Finasteride groups and the Test for interaction, respectively. Cholesterol units: mg/dl.